Structure Therapeutics Inc.

GPCR Stock Healthcare Biotechnology
$47.13
+1.22 (+2.66%)
Price as of Sep 01, 2026 market close

Performance

1 Month
-2.5%
3 Months
+26.7%
YTD
-32.2%
1 Year
+144.2%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
118.9%
Largest decline max drawdown, since Aug 2025
-61.7%
Risk-adjusted return Sharpe ratio, 1-year
1.17

Own GPCR?

See how GPCR contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.